2017-2023年美国糖尿病患病率、认知和控制

IF 4.7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Jessica L Harding , Chengcheng Hu , Jithin Sam Varghese , Rodrigo M Carrillo-Larco , Mohammed K Ali
{"title":"2017-2023年美国糖尿病患病率、认知和控制","authors":"Jessica L Harding ,&nbsp;Chengcheng Hu ,&nbsp;Jithin Sam Varghese ,&nbsp;Rodrigo M Carrillo-Larco ,&nbsp;Mohammed K Ali","doi":"10.1016/j.diabet.2025.101659","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>We compared diabetes prevalence, awareness, and control pre versus post the Covid-19 pandemic.</div></div><div><h3>Methods</h3><div>This was a cross-sectional analysis of the U.S. National Health and Nutrition Examination Surveys pre (2017–2020) and post (2021–2023) the pandemic. We included all non-pregnant adults (aged ≥ 20 years) who had undergone biomedical testing. Diagnosed and undiagnosed diabetes was defined as self-reported diabetes and no self-reported diabetes with HbA1c &gt;6.5 % or fasting plasma glucose ≥126 mg/dL, respectively. Among diagnosed diabetes, we estimated proportions achieving glycemic (HbA1c &lt; 7.0 %), blood pressure (&lt; 130/80 mmHg), and cholesterol control (non-high-density lipoprotein &lt; 130mg/dl), and use of blood pressure and lipid lowering medications.</div></div><div><h3>Results</h3><div>The prevalence of total diabetes, diagnosed diabetes, undiagnosed diabetes, and proportion of diabetes that was undiagnosed remained stable between pre and post pandemic periods: from 16.2 % [95 %CI: 14.3–18.1] to 15.8 % [13.7–17.9], from 11.7 % [10.1–13.2] to 11.3 % [9.4–13.2], from 4.6 % [3.8–5.3]) to 4.5 % [3.4–5.6]), and from 28.1 % [24.3–31.8] to 28.4 % [21.9–35.0], respectively. Among those with diagnosed diabetes, glycemia, blood pressure, lipid control, and use of blood pressure or lipid medication did not significantly change.</div></div><div><h3>Conclusions</h3><div>Between 2017–2020 and 2021–2023, there were no significant changes in diabetes prevalence, awareness, and control in the U.S. population.</div></div>","PeriodicalId":11334,"journal":{"name":"Diabetes & metabolism","volume":"51 4","pages":"Article 101659"},"PeriodicalIF":4.7000,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Diabetes prevalence, awareness, and control in the United States, 2017-2023\",\"authors\":\"Jessica L Harding ,&nbsp;Chengcheng Hu ,&nbsp;Jithin Sam Varghese ,&nbsp;Rodrigo M Carrillo-Larco ,&nbsp;Mohammed K Ali\",\"doi\":\"10.1016/j.diabet.2025.101659\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><div>We compared diabetes prevalence, awareness, and control pre versus post the Covid-19 pandemic.</div></div><div><h3>Methods</h3><div>This was a cross-sectional analysis of the U.S. National Health and Nutrition Examination Surveys pre (2017–2020) and post (2021–2023) the pandemic. We included all non-pregnant adults (aged ≥ 20 years) who had undergone biomedical testing. Diagnosed and undiagnosed diabetes was defined as self-reported diabetes and no self-reported diabetes with HbA1c &gt;6.5 % or fasting plasma glucose ≥126 mg/dL, respectively. Among diagnosed diabetes, we estimated proportions achieving glycemic (HbA1c &lt; 7.0 %), blood pressure (&lt; 130/80 mmHg), and cholesterol control (non-high-density lipoprotein &lt; 130mg/dl), and use of blood pressure and lipid lowering medications.</div></div><div><h3>Results</h3><div>The prevalence of total diabetes, diagnosed diabetes, undiagnosed diabetes, and proportion of diabetes that was undiagnosed remained stable between pre and post pandemic periods: from 16.2 % [95 %CI: 14.3–18.1] to 15.8 % [13.7–17.9], from 11.7 % [10.1–13.2] to 11.3 % [9.4–13.2], from 4.6 % [3.8–5.3]) to 4.5 % [3.4–5.6]), and from 28.1 % [24.3–31.8] to 28.4 % [21.9–35.0], respectively. Among those with diagnosed diabetes, glycemia, blood pressure, lipid control, and use of blood pressure or lipid medication did not significantly change.</div></div><div><h3>Conclusions</h3><div>Between 2017–2020 and 2021–2023, there were no significant changes in diabetes prevalence, awareness, and control in the U.S. population.</div></div>\",\"PeriodicalId\":11334,\"journal\":{\"name\":\"Diabetes & metabolism\",\"volume\":\"51 4\",\"pages\":\"Article 101659\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2025-05-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes & metabolism\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1262363625000540\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes & metabolism","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1262363625000540","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

我们比较了Covid-19大流行前后的糖尿病患病率、意识和控制。方法:本研究是对美国全国健康和营养调查(2017-2020年)和(2021-2023年)大流行前后的横断面分析。我们纳入了所有接受过生物医学检测的未怀孕成人(年龄≥20岁)。确诊和未确诊糖尿病分别定义为HbA1c≥6.5%或空腹血糖≥126 mg/dL的自我报告糖尿病和无自我报告糖尿病。在确诊的糖尿病患者中,我们估计了达到血糖(HbA1c <;7.0%),血压(<;130/80 mmHg)和胆固醇控制(非高密度脂蛋白<;130毫克/分升),并使用降血压和降脂药物。结果总糖尿病、确诊糖尿病、未确诊糖尿病和未确诊糖尿病的患病率在大流行前后保持稳定,分别为16.2% [95% CI: 14.3-18.1] ~ 15.8%[13.7-17.9]、11.7%[10.1-13.2]~ 11.3%[9.4-13.2]、4.6%[3.8-5.3]~ 4.5%[3.4-5.6]、28.1%[24.3-31.8]~ 28.4%[21.9-35.0]。在诊断为糖尿病的患者中,血糖、血压、脂质控制和使用血压或脂质药物没有显著变化。在2017-2020年和2021-2023年期间,美国人口中糖尿病患病率、认知和控制没有显著变化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Diabetes prevalence, awareness, and control in the United States, 2017-2023

Introduction

We compared diabetes prevalence, awareness, and control pre versus post the Covid-19 pandemic.

Methods

This was a cross-sectional analysis of the U.S. National Health and Nutrition Examination Surveys pre (2017–2020) and post (2021–2023) the pandemic. We included all non-pregnant adults (aged ≥ 20 years) who had undergone biomedical testing. Diagnosed and undiagnosed diabetes was defined as self-reported diabetes and no self-reported diabetes with HbA1c >6.5 % or fasting plasma glucose ≥126 mg/dL, respectively. Among diagnosed diabetes, we estimated proportions achieving glycemic (HbA1c < 7.0 %), blood pressure (< 130/80 mmHg), and cholesterol control (non-high-density lipoprotein < 130mg/dl), and use of blood pressure and lipid lowering medications.

Results

The prevalence of total diabetes, diagnosed diabetes, undiagnosed diabetes, and proportion of diabetes that was undiagnosed remained stable between pre and post pandemic periods: from 16.2 % [95 %CI: 14.3–18.1] to 15.8 % [13.7–17.9], from 11.7 % [10.1–13.2] to 11.3 % [9.4–13.2], from 4.6 % [3.8–5.3]) to 4.5 % [3.4–5.6]), and from 28.1 % [24.3–31.8] to 28.4 % [21.9–35.0], respectively. Among those with diagnosed diabetes, glycemia, blood pressure, lipid control, and use of blood pressure or lipid medication did not significantly change.

Conclusions

Between 2017–2020 and 2021–2023, there were no significant changes in diabetes prevalence, awareness, and control in the U.S. population.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Diabetes & metabolism
Diabetes & metabolism 医学-内分泌学与代谢
CiteScore
12.00
自引率
4.20%
发文量
86
审稿时长
13 days
期刊介绍: A high quality scientific journal with an international readership Official publication of the SFD, Diabetes & Metabolism, publishes high-quality papers by leading teams, forming a close link between hospital and research units. Diabetes & Metabolism is published in English language and is indexed in all major databases with its impact factor constantly progressing. Diabetes & Metabolism contains original articles, short reports and comprehensive reviews.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信